Roche Holdings AG received CE mark approval for the integration of its artificial intelligence-enabled continuous glucose ...

When Robert Kennedy Jr. announced the cancellation of 22 projects related to mRNA vaccines and the end of new investments in ...

For enquiring minds that want to know, Susan Monarez laid out the details Sept. 17 of how she was fired as CDC director for the Senate Health, Education, Labor and Pensions Committee.

People have some inability to focus on [Regeneron Pharmaceuticals Inc.’s] pipeline,” which stands as “the most prolific in the industry, I would dare to say,” CEO Leonard Schleifer remarked during the ...

Three-year-old Areteia Therapeutics Inc. hit the primary endpoint in its Exhale-4 phase III study of dexpramipexole for ...

Japan’s Pharmaceuticals and Medical Devices Agency has traditionally been less than receptive to clinical data from other ...

In its second deal with Novartis AG of the past 11 months, Monte Rosa Therapeutics Inc. is getting $120 million up front to ...

Recent comments from CDER Director George Tidmarsh suggesting that the agency may be backing away from the use of its ...

Dualitas Therapeutics Inc. exited stealth mode with a $65 million series A investment that was co-led by Versant Ventures and ...

On the heels of the announcement of German bionics developer Ottobock SE KGaA's pending IPO and more than 20 med-tech IPOs ...

CSL Ltd. inked a potential $2.1 billion deal with Dutch biotech company Varmx BV to develop VMX-C001 as a new treatment to ...

Artificial intelligence is no longer just a supporting tool in biotechnology – it is beginning to define the way drugs are ...